PARIS, France – April 2, 2009 – Cegedim Dendrite announces today the release of Mobile Intelligence Key Account Management, a dedicated CRM (Customer Relationship Management) solution to optimize brand management and relationships for life sciences industry’s key accounts.
“The shift from share of voice to account relationships is a reality in many countries. Key accounts influence the way drugs are reimbursed, prescribed and delivered and have become pharmaceutical and life sciences industry’s largest customers” explains Laurent Labrune, Chief Executive Officer of Cegedim Dendrite.
To face this evolving and complex environment, Pharmaceutical companies require a specific solution which matches their business processes. By helping them manage by account the complex decision making processes and multiple stakeholder’s interactions on key topics, such as formulary agreements, Mobile Intelligence Key Account Management (KAM) solution bridges the gap.
“Our new version of Mobile Intelligence squarely addresses the pharmaceutical industry’s need to get a 360-degree view of its most important accounts and their environment, thus boosting customer service to unprecedented levels” says Laurent Labrune. “Cegedim Dendrite is committed to developing solutions and services to meet the business needs of the life sciences industry. The management of relationships between key stakeholders is a competitive advantage for our customers”
A recent report from leading industry analyst Gartner (Ref. G00162799 – Nov. 2008) recommends evaluating Cegedim Dendrite Mobile Intelligence KAM solution for pharmaceutical companies seeking a comprehensive team business management tool from objective setting to execution.
To read the full Gartner report and to see how Mobile Intelligence Key Account Management Module can improve your efficiency, visit www.cegedimdendrite.com/Demo-KAM
About Cegedim Dendrite
Cegedim Dendrite provides the pharmaceutical companies around the world with vital support for successful Customer Relationship Management (CRM) activities. With nearly 200,000 sales representatives using its products worldwide, Cegedim Dendrite is the world’s leading CRM provider for the life sciences industry. This business unit, created in May 2007 when the France-based Cegedim S.A. Group acquired Dendrite International, also provides sales, marketing and regulatory compliance solutions in more than 80 countries. To learn more, please see our website: www.cegedimdendrite.com.
About CEGEDIM:
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies. The world leader in pharmaceutical CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs more than 8,400 people in 80 countries and generated revenue of €849 million in 2008. To learn more, please visit our website: www.cegedim.com.
Listed on NYSE Euronext Paris, compartment B – ISIN FR0000053506 – Reuters CGDM.PA – Bloomberg CGM
Media Inquiries:
Cegedim Dendrite
Karine Renaud
Communications Manager EMEA
Tel: +33 (0)1 49 09 23 74
karine.renaud@cegedimdendrite.com
CEGEDIM Group
Aude Balleydier
Media Relations
Tel: + 33 (0)1 49 09 68 81
aude.balleydier@cegedim.fr